AMWL - NYSE
American Well Corporation
$8.46
+0.65%American Well Corporation operates as a telehealth software company that enables digital delivery of care for healthcare. The company products offer urgent care; scheduled visits; acute behavioral health; telestroke; pediatrics; retail health, school health, and home settings. Its application offers urgent care; pediatrics; therapy; menopause nutrition; end-stage renal disease and dialysis; dermatology care; behavioral health therapy; and musculoskeletal care. The company also provides telemedicine equipment, including telemedicine carts, peripherals, tyto care, TV kits, tablets, and kiosks. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.
At a Glance
Live SnapshotAmerican Well Corporation Management Team
Dr. Ido Schoenberg M.D.
Chairman & Chief Executive Officer
Compensation
$2,115,004
Dr. Cynthia Horner FAAFP, M.D.
Chief Medical Officer & President of Amwell Medical Group
Ms. Amber Howe
Chief People Officer
Mr. Dan Zamansky
Chief Product & Technology Officer
Dr. Roy Schoenberg M.D., M.P.H.
Executive Vice Chairman
Compensation
$2,682,079
Mr. Mark J. Hirschhorn CPA
Executive Vice President, Chief Operating Officer & Chief Financial Officer
Compensation
$991,178
Ms. Sue Dooley
Head of Investor Relations
Anna Nesterova
Head of Legal
Ms. Phyllis I. Gotlib
President of Amwell International
Compensation
$931,547
Mr. Paul Francis McNeice
Vice President of Accounting
American Well Corporation Insider Positioning
During the last 12 months, insiders have purchased $5K and sold $586K worth of AMWL shares, resulting in $581K of net selling activity.
3 Months
670
4.94K
9.7K
51.22K
-46K
-$46K
3-6 Months
0
0.00
27.9K
142.39K
-142K
-$142K
6-9 Months
0
0.00
13.5K
77.01K
-77K
-$77K
9-12 Months
0
0.00
44.9K
315.16K
-315K
-$315K
Top Buyers
Schoenberg Ido
Director, Officer: Chairman, Co-Ceo
$5K
Top Sellers
Zamansky Dmitry
Officer: Chief Product & Tech. Officer
$247K
Gotlib Phyllis
Officer: President, International
$176K
Jackson Deborah C
Director
$96K
Hirschhorn Mark
Officer: Chief Financial Officer
$57K
Mcneice Paul Francis
Officer: Chief Accounting Officer
$11K
Insider Activity Analysis
Net Insider Sentiment
Strong bearish signal with $581K net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Buy/Sell Ratio
Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.
Recent Trend (3 Months)
Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.
Insider Participation
5 insider sellers vs. 1 buyers. Widespread selling across multiple insiders may signal concerns.
Insider Activity Insight
Multiple red flags: Heavy selling, numerous sellers, and continued recent selling create a concerning pattern. Investigate fundamental drivers and consider whether company guidance or industry conditions have deteriorated.
SEC Filings
AMWL - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 23, 2026 | April 23, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 23, 2025 | April 22, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | April 26, 2024 | June 18, 2024 | 2024 | |
DEF 14A DEF 14A N/A | April 28, 2023 | April 28, 2023 | ||
DEF 14A DEF 14A 2022 N/A | April 29, 2022 | June 13, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | April 30, 2021 | June 15, 2021 | 2021 |
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.